What is the recommended schedule for tetanus‑containing vaccines (DTaP, Tdap, Td) for infants, children, adolescents, adults, pregnant women, and for wound management?

Tetanus Vaccine Schedule

All individuals should receive a primary series of tetanus-containing vaccines followed by booster doses every 10 years throughout life, with specific timing and formulations varying by age group. 1

Infants and Children (Birth to Age 6 Years)

• Primary series: Administer DTaP (diphtheria, tetanus, and acellular pertussis) vaccine as a 5-dose series at ages 2,4,6,15-18 months, and 4-6 years 1
• This series provides foundational protection against tetanus, diphtheria, and pertussis during the most vulnerable years 2

Children and Adolescents (Ages 7-18 Years)

• Single Tdap dose: Administer one dose of Tdap at age 11-12 years, preferably during a preventive care visit 1
• Booster doses: After the adolescent Tdap dose, give either Td or Tdap every 10 years throughout life 1
• Catch-up for unvaccinated/undervaccinated: If a child aged 7-18 years has incomplete vaccination history, give 1 dose of Tdap (preferably as the first dose), followed by additional doses of either Td or Tdap at ≥4 weeks and 6-12 months to complete a 3-dose series 1

Adults (Age ≥19 Years)

• Single Tdap dose: All adults who have never received Tdap should receive 1 dose, regardless of interval since last tetanus-containing vaccine 1
• Decennial boosters: After receiving Tdap, administer either Td or Tdap every 10 years throughout life 1
• Catch-up for unvaccinated adults: Administer a 3-dose series consisting of 1 dose of Tdap, followed by either Td or Tdap at least 4 weeks later, then a final dose of either Td or Tdap 6-12 months after the second dose 1

Pregnant Women

Administer Tdap during EVERY pregnancy at 27-36 weeks' gestation, preferably during the earlier part of this period, regardless of prior Tdap vaccination history. 1

• This timing maximizes maternal antibody transfer to the newborn, providing critical protection during the first 2 months of life before the infant can begin their own vaccination series 3, 4
• Tdap may be given at any time during pregnancy if needed for wound management or other circumstances 1, 3
• For pregnant women who need ≥2 doses to complete primary immunization, at least 1 dose should be Tdap administered according to the 27-36 week guidance; additional doses may be either Td or Tdap 1

Wound Management

For tetanus prophylaxis in wound management, a tetanus-containing vaccine is indicated when >5 years have elapsed since the last dose. 1

Algorithm for Wound Management (Age ≥7 Years):

• Clean, minor wounds:

  • If >10 years since last tetanus vaccine: Give Td or Tdap 5
  • If ≤10 years since last vaccine: No vaccine needed 5

• All other wounds (contaminated, puncture, avulsions, burns):

  • If >5 years since last tetanus vaccine: Give Td or Tdap 5
  • If ≤5 years since last vaccine: No vaccine needed 5
  • Consider tetanus immune globulin (TIG) for high-risk wounds in inadequately vaccinated persons 1, 5

Specific Wound Management Recommendations:

• Never received Tdap or history unknown: Prefer Tdap for persons aged ≥11 years 1
• Previously received Tdap (non-pregnant): Either Td or Tdap may be used 1
• Pregnant women: Use Tdap if a tetanus-containing vaccine is indicated 1
• Minimum interval: Tdap may be given as soon as 5 years after any prior tetanus-containing vaccine for wound management 6

Important Clinical Considerations

Flexibility in Product Selection

The 2019 ACIP update allows either Td or Tdap to be used interchangeably in situations where previously only Td was recommended, including decennial boosters and catch-up schedules after the first Tdap dose has been received 1. This provides greater point-of-care flexibility for providers 1.

Common Pitfalls to Avoid

• Do not delay Tdap: When Tdap is indicated, administer it regardless of the interval since the last tetanus-containing vaccine 1
• Do not restart series: For persons with incomplete vaccination history, continue from where they left off rather than restarting the entire series 1
• Do not use DTaP in persons ≥7 years: DTaP is not indicated for this age group; use Tdap or Td instead 1
• Do not give boosters more frequently than recommended: More frequent boosters can accentuate side effects without added benefit 5

Safety Profile

Tdap can be safely administered at intervals as short as 18 months after a previous tetanus-containing vaccine, though slight increases in injection site reactions may occur with shorter intervals 7. No serious adverse events, whole limb swelling, or Arthus-like reactions have been reported with shortened intervals 7.

Undervaccination Risks

Receiving fewer than the recommended number of doses is associated with significantly higher pertussis risk (adjusted relative risk 3.2-4.8 depending on which dose is missed), making completion of the series critical even if some delay occurs 2.